Annual Net Income
-$121.83 M
-$6.39 M-5.54%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual net profit is currently -$121.83 million, with the most recent change of -$6.39 million (-5.54%) on 31 December 2023. During the last 3 years, it has fallen by -$64.90 million (-114.01%). PRLD annual net income is now -729.92% below its all-time high of -$14.68 million, reached on 31 December 2018.PRLD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$32.27 M
+$2.47 M+7.11%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly net profit is currently -$32.27 million, with the most recent change of +$2.47 million (+7.11%) on 30 September 2024. Over the past year, it has dropped by -$1.66 million (-5.43%). PRLD quarterly net income is now -379.22% below its all-time high of -$6.73 million, reached on 30 September 2019.PRLD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$131.52 M
-$1.66 M-1.28%
30 September 2024
Summary:
Prelude Therapeutics Incorporated TTM net profit is currently -$131.52 million, with the most recent change of -$1.66 million (-1.28%) on 30 September 2024. Over the past year, it has dropped by -$14.12 million (-12.03%). PRLD TTM net income is now -1853.03% below its all-time high of -$6.73 million, reached on 30 September 2019.PRLD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.5% | -5.4% | -12.0% |
| 3 y3 years | -114.0% | -5.2% | -34.1% |
| 5 y5 years | -729.9% | -379.2% | -1853.0% |
PRLD Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -114.0% | at low | -17.9% | +7.1% | -34.1% | at low |
| 5 y | 5 years | -729.9% | at low | -379.2% | +7.1% | -1853.0% | at low |
| alltime | all time | -729.9% | at low | -379.2% | +7.1% | -1853.0% | at low |
Prelude Therapeutics Incorporated Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$32.27 M(-7.1%) | -$131.52 M(+1.3%) |
| June 2024 | - | -$34.74 M(+10.5%) | -$129.85 M(+3.4%) |
| Mar 2024 | - | -$31.43 M(-5.0%) | -$125.55 M(+3.0%) |
| Dec 2023 | -$121.83 M(+5.5%) | -$33.08 M(+8.1%) | -$121.83 M(+3.8%) |
| Sept 2023 | - | -$30.61 M(+0.6%) | -$117.40 M(+0.6%) |
| June 2023 | - | -$30.43 M(+9.8%) | -$116.75 M(+2.7%) |
| Mar 2023 | - | -$27.72 M(-3.2%) | -$113.69 M(-1.5%) |
| Dec 2022 | -$115.44 M(+3.4%) | -$28.64 M(-4.4%) | -$115.44 M(-3.5%) |
| Sept 2022 | - | -$29.96 M(+9.4%) | -$119.64 M(-0.6%) |
| June 2022 | - | -$27.37 M(-7.1%) | -$120.37 M(+0.4%) |
| Mar 2022 | - | -$29.46 M(-10.3%) | -$119.86 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$111.69 M(+96.2%) | -$32.84 M(+7.0%) | -$111.69 M(+13.9%) |
| Sept 2021 | - | -$30.69 M(+14.2%) | -$98.10 M(+16.5%) |
| June 2021 | - | -$26.86 M(+26.1%) | -$84.17 M(+22.5%) |
| Mar 2021 | - | -$21.30 M(+10.6%) | -$68.72 M(+20.7%) |
| Dec 2020 | -$56.93 M(+106.5%) | -$19.25 M(+14.9%) | -$56.93 M(+19.3%) |
| Sept 2020 | - | -$16.76 M(+46.9%) | -$47.72 M(+26.6%) |
| June 2020 | - | -$11.41 M(+19.9%) | -$37.69 M(+43.4%) |
| Mar 2020 | - | -$9.51 M(-5.3%) | -$26.28 M(+56.7%) |
| Dec 2019 | -$27.57 M(+87.8%) | -$10.04 M(+49.1%) | -$16.77 M(+149.1%) |
| Sept 2019 | - | -$6.73 M | -$6.73 M |
| Dec 2018 | -$14.68 M | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual net profit?
- What is the all time high annual net income for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual net income year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly net profit?
- What is the all time high quarterly net income for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly net income year-on-year change?
- What is Prelude Therapeutics Incorporated TTM net profit?
- What is the all time high TTM net income for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM net income year-on-year change?
What is Prelude Therapeutics Incorporated annual net profit?
The current annual net income of PRLD is -$121.83 M
What is the all time high annual net income for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual net profit is -$14.68 M
What is Prelude Therapeutics Incorporated annual net income year-on-year change?
Over the past year, PRLD annual net profit has changed by -$6.39 M (-5.54%)
What is Prelude Therapeutics Incorporated quarterly net profit?
The current quarterly net income of PRLD is -$32.27 M
What is the all time high quarterly net income for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly net profit is -$6.73 M
What is Prelude Therapeutics Incorporated quarterly net income year-on-year change?
Over the past year, PRLD quarterly net profit has changed by -$1.66 M (-5.43%)
What is Prelude Therapeutics Incorporated TTM net profit?
The current TTM net income of PRLD is -$131.52 M
What is the all time high TTM net income for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM net profit is -$6.73 M
What is Prelude Therapeutics Incorporated TTM net income year-on-year change?
Over the past year, PRLD TTM net profit has changed by -$14.12 M (-12.03%)